Chronic myeloid leukaemia trials in Hong Kong

2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Not yet taking people in Hong Kong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Age

  18 years and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408
• Phase 2Taking people
  Oral-ATO for TP53-mutated Myeloid Malignancies

  Where

  Hong Kong

  Age

  18 years and over

  People

  30

  Run by

  The University of Hong Kong

  See details and how to joinNCT06778187